群益投信理財網
Trading Information

The fund has been approved or acknowledged for issue by the Financial Supervisory Commission, but it does not represent that the fund is free of risks. Past performance of the management company should not be construed as a guarantee on minimum returns. Except for its duties as a prudent manager, the management company is not liable for the gains or losses of the fund, and nor does it guarantee minimum returns. Investors are advised to comprehend the fund’s prospectus or simplified prospectus before subscribing. Our funds are not guaranteed by deposit insurance, insurance and stability fund or other related security mechanism, so in the lost of part or all principal , investors should take risk by oneself.

CAPITAL SZSE SME PRICE INDEX EXCHANGE TRADED FUND
The tracked and duplicated “SZSE SME Price Index” performance is prepared and calculated by Shenzhen Securities Information Co., Ltd., (hereinafter referred to as SSIC) under the commission of the Shenzhen Stock Exchange (hereinafter referred to as SZSE). The Shenzhen Securities Information Co., Ltd., takes rigorous precautions to ensure the timeliness, accuracy, and completeness of target indices but does not make any guarantees. The SZSE and SSIC are not responsible for the loss or damage incurred by the inaccuracy, delay or omission of the target index, nor are they obligated to provide suggestions or bear liability for any errors of beneficiaries, funds, management companies, or any other entities. The right to the SZSE SME Price Index is owned by the SZSE and SSIC, and the displayed SZSE SME Price Index trademark was used in authorization by the SICC. The fund takes a passive management approach, targeting fund investment portfolios by duplicating and tracking SZSE SME Price Index performance. Fund investment performance is dependent on the trend of the target index. When the composing shares or the target index fluctuates severely or falls, the net asset value of the fund is at risk of significant fluctuation. This mutual fund invests directly in the China region securities market, by means of the approved QFII investment quota obtained by the management company, and is subjected to the relevant policy restrictions and bears the risks of policy changes. The exchange and capital management restrictions may possibly affect the fluidity of this fund, and be at risk of liquidity. In addition, the QFII quota can only be invested in RMB priced investment products by exchanging the currency held by this fund into USD, then exchanging into RMB after being directed into the China region, thus this fund may also incur the risk of exchange restrictions and exchange rate fluctuations. In responding to the China region tax authority’s relevant tax regulations on capital gains of A-share investments, the management company holds the right to tax reserves for this fund on the China region A-share investments capital gains. However, changes in the China region tax authority definitions on relevant tax regulations may incur the possible risk of reserves being inconsistent to the final tax burden. The management company will pre-charge subscribers to this fund since the day of listing (including said date) a subscription price based on 110% of the “subscription price at market value” as expressed in the “portfolio composition file”, plus a subscription fee. The fund withholds rights to decline, suspend subscription services, or repurchase subscription based on the account of the approved QFII investment quota obtained by the management company and specific elements regulated by the relevant laws of the China region. Net asset value per equity during fundraising periods before listing does not equate to the price after listing. Subscribers must bear the risk of price discounts or premiums caused by price fluctuations during position opening. There are no fluctuation restraints to strike prices after listing, but must be conducted in accordance with the relevant regulations of the Taiwan Stock Exchange.

CAPITAL NASDAQ BIOTECHNOLOGY INDEX EXCHANGE TRADED FUND
The tracked and duplicated “Nasdaq Biotechnology Index (NBI)” is prepared and calculated by Nasdaq, Inc. The Capital Investment Trust NBI indexation duplicates and tracks Nasdaq Biotechnology Index performance as a fund investment portfolio target. Fund investment performance is dependent on the trend of the target index. When the composing shares or target index fluctuates severely or falls, the net asset value of the fund is at risk of significant fluctuation. The Capital Investment Trust NBI ETF fund is not issued, promoted, or sold by Nasdaq., Inc., or its affiliates (hereinafter referred to as Corporations), nor have the Corporations in any way sponsored or endorsed this fund. The Corporations have not made explanations on the accuracy on the legitimacy, adequacy, data introduction, and relevant information disclosure. The Corporations make no warranty or statement expressed or implied to beneficiaries and public investors of the Capital Investment Trust NBI ETF fund on whether the fund is worthy of investment, or the tracking ability of the Nasdaq Biotechnology Index to overall securities market performance. The relations between Corporations and the management company is restricted only to its authorized use of Nasdaq®, Nasdaq, Inc., The Nasdaq Stock Market, Nasdaq and use of the Nasdaq Biotechnology Index. Nasdaq is not obligated to take into consideration the needs of the management company and this fund when composing, calculating and determining the Nasdaq Biotechnology Index. The Corporations are not responsible for, nor participated in the determination of, the timing, prices at or quantities of the Capital Investment Trust NBI ETF fund issued, or in the determination or calculation by which the Capital Investment Trust NBI ETF fund is to be converted into cash.

The Corporations do not bear any obligations or legal responsibility for the administration, marketing or trading of the Capital Investment Trust NBI ETF fund. The Corporations do not guarantee absolute continuous accuracy and/or calculation of the Nasdaq Biotechnology Index and any of its data included therein. The Corporations make no statement and warranty, expressed or implied, as to results obtained by the management company, the Capital Investment Trust NBI ETF fund, any other individual or entity from the use of the Nasdaq Biotechnology Index, or any of its data included therein. The Corporations make no express or implied warranties, and expressly disclaim all warranties of merchantability or fitness for a particular purpose or use with respect to the [Nasdaq Biotechnology Index]® or any data included therein. Without limiting any of the foregoing, the Corporations expressly disclaim any and all liability for any lost profits, and special, incidental, indirect, consequential or punitive damages, even if notified of the possibility of such damages. The management company will pre-charge subscribers of the NBI ETF fund since the day of listing (including said date) a subscription price based on 110% of the “subscription price at market value” as expressed in the “portfolio composition file”, plus a subscription fee. The Net asset value per equity during fund raising periods of the NBI ETF fund before listing does not equate to the price after listing. Subscribers must bear the risk of price discounts or premiums caused by price fluctuations during position opening. The management company does not accept beneficial right units repurchase of this fund before the listing date (said date excluded). There are no fluctuation restraints to strike prices after ETF listing but must be conducted in accordance with relevant regulations of the Taiwan Stock Exchange.

Capital TAIEX Leveraged 2X ETF and Capital TAIEX Inversed-1X ETF 
These two sub-funds’ indexation duplicates and tracks the “TWSE TAIEX Daily 2X Leveraged Index” and “TWSE TAIEX Daily 1X Inverse Index” performance as the fund investment portfolio management target. The sub-funds’ performance of this fund is dependent on the trend of the target index. When the index price of the target fluctuates severely or falls, the net asset value of the respective sub-funds is at risk of significant fluctuation. The Capital Investment Trust has obtained the authorization from the Taiwan Stock Exchange Corporation to use the TWSE TAIEX Daily 2X Leveraged Index and TWSE TAIEX Daily 1X Inverse Index. The Capital Investment Trust TAIEX Daily 2X Leveraged Index Fund and TAIEX Daily 1X Inverse Index Fund possess leverage and inverse risks. The respective fund differs from traditional ETF; the investment profit and loss is deeply affected by market fluctuation and compound interest. This fund is not suited to investors looking for long-term investments and who are unfamiliar with targeted daily investment returns. Before trading, investors should go through the details in the fund prospectus to ensure sufficient understanding of the fund risk and characteristics involved. The initial investor trading of the sub-funds should conform to investor requisites as stipulated in the “Taiwan Stock Exchange Corporation Rules Governing Trading of Beneficial Certificates” with a signed risk disclosure statement before beginning trade. The sub-funds “Capital Investment Trust TAIEX Daily 2X Leveraged Index Fund” and the “Capital Investment TAIEX Daily 1X Inverse Index fund” are not sponsored, endorsed, sold or promoted by the Taiwan Stock Exchange Corporation (TWSE); nor does the TWSE provide any warranty or statement, expressly or implied, on expected results from the use of the “TWSE TAIEX Daily 2X Leveraged Index” and the “TWSE TAIEX Daily 1X Inverse Index” and/or any numbers of the index presented at specific dates and times. The “TWSE TAIEX Daily 2X Leveraged Index” and “TWSE TAIEX Daily 1X Inverse Index” are prepared and calculated by the TWSE, though the TWSE is not liable for any faults or damage responsibilities from errors in the “TWSE TAIEX Daily 2X Leveraged Index” and the “TWSE TAIEX Daily 1X Inverse Index”, nor is the TWSE obligated to notify anyone of any errors in the index. 

CAPITAL DOW JONES U.S. REAL ESTATE INDEX EXCHANGE TRADED FUND
The tracked and duplicated “Dow Jones U.S. Real Estate Index ” is prepared and calculated by Standard & Poor’s Financial Services LLC. The Capital Investment Trust Dow Jones U.S. Real Estate indexation duplicates and tracks Dow Jones U.S. Real Estate Index performance as a fund investment portfolio target. Fund investment performance is dependent on the trend of the target index. When the composing shares or target index fluctuates severely or falls, the net asset value of the fund is at risk of significant fluctuation. The Capital Investment Trust Dow Jones U.S. Real Estate Index ETF fund is not issued, promoted, or sold by S&P Financial Services LLC., or its affiliates (hereinafter referred to as Corporations), nor have the Corporations in any way sponsored or endorsed this fund. The Corporations have not made explanations on the accuracy on the legitimacy, adequacy, data introduction, and relevant information disclosure. The Corporations make no warranty or statement expressed or implied to beneficiaries and public investors of the Capital Investment Trust Dow Jones Real Estate Index ETF fund on whether the fund is worthy of investment, or the tracking ability of the Dow Jones U.S. Real Estate Index to overall securities market performance. The information and data are created and managed by S&P Dow Jones Indices LLC, will be displayed on www.spdji.com.Without limiting any of the foregoing, the Corporations expressly disclaim any and all liability for any lost profits, and special, incidental, indirect, consequential or punitive damages, even if notified of the possibility of such damages. There are no fluctuation restraints to strike prices after ETF listing but must be conducted in accordance with relevant regulations of the Taiwan Stock Exchange. Withholding any expense before paying dividend out, fund dividend payment maybe calculated form yield or principal, and cause original cost lost. The Fund dividend composed items will be announced on official website. Dividend yield of the fund does not represent the return of the fund, and past dividend yield does not represent future dividend yield; the net value of the fund may fluctuate as a result of market factors. The fund is suitable for non-conservative investors who can take high risk. The management company does not accept beneficial right units repurchase of this fund before the listing date (said date excluded).

CAPITAL ICE BofA 15+ YEAR US TELECOMMUNICATIONS INDEX EXCHANGE TRADED & CAPITAL ICE BofA 15+ YEAR US TECHNOLOGY & ELECTRONICS INDEX EXCHANGE TRADED FUND & CAPITAL ICE BofA 10+ YEAR US BANKING AND BROKERAGE INDEX EXCHANGE TRADED FUND
All sub-funds of the Fund are passively managed. They adopt the strategy of replicating and tracking performance of the benchmark index, which are the goals of the Fund's portfolio management. The movement of the benchmark index will determine the Fund’s investment performance. Net asset value may be prone to high volatility on occasions where compositions of the benchmark index exhibit extreme volatility.The Fund's sub-funds may invest in U.S. Rule 144A offerings. These bonds are privately placed in nature and may be prone to a lack of liquidity, inadequate disclosure of financial information, or higher volatility caused by non-transparent price information. ICE BofA 15+ Year US Telecommunications Index, ICE BofA 15+ Year US Technology & Electronics Index and ICE BofA 10+ Year US Banking and Brokerage Index SM/® (hereinafter referred to as "the Index Series") are products of ICE Data Indices, LLC and affiliated companies (collectively referred to as "ICE Data"), and have been licensed for use by Capital Investment Trust Corporation (Capital ITC). ICE Data has been licensed to Capital ITC for specific purposes. Capital ITC Industry-focused Investment-grade Corporate Bond FoF ETF (hereinafter referred to as "the Fund") is not a product sponsored, sold or promoted by ICE data Incorporated and affiliated companies (collectively referred to as "ICE data"). ICE data offers no assurance whatsoever as to whether the Fund is suitable for general or specific investors, and makes no statement or guarantee about its strategy, performance, or ability to track market movements using the indices, whether implicitly or explicitly to Fund holders or any member of the public. The relationship between ICE data and Capital ITC is characterized only by the licensing of trademarks, business names, indices, and index compositions. The Index Series are determined, compiled and calculated solely by ICE data, which the licensee, the product and its holders are not involved in any way. ICE data is neither responsible nor involved in determining the timing, pricing or quantity of product offering, or rules or calculations concerning the pricing, sale, subscription or redemption of the product. ICE data is neither obligated nor responsible for the management, marketing or trading of this product. ICE data does not guarantee the accuracy and completeness of the Index Series or its data. ICE data is not responsible for any errors, negligence, non-usability or disruption of the Index Series. ICE data offers no guarantee whatsoever, whether implicitly or explicitly, to the licensee, product holders or any other party, or for any results derived from the use of index or index data. ICE data offers no guarantee whatsoever, whether implicitly or explicitly, over the Index Series or its data. ICE data explicitly denies any guarantee over the marketability and usability of the Index Series for any party or any purpose. Without limiting the above, ICE data is not responsible for any losses of indirect, special, incidental, punitive or inevitable nature, including but not limited to loss of profit, trading loss, loss of time and loss of reputation, even if possibility of such losses is known prior to occurrence.

CAPITAL ICE 15+ YEAR AAA-AA US CORPORATE EXCHANGE TRADED FUND; CAPITAL ICE 15+ YEAR US UTILITY EXCHANGE TRADED FUND; CAPITAL ICE INTERNATIONAL 15+ YEAR US EMERGING MARKETS EXTERNAL SOVEREIGN EXCHANGE TRADED FUND All sub-funds of the Fund are passively managed. They adopt the strategy of replicating and tracking performance of the benchmark index, which are the goals of the Fund's portfolio management. The movement of the benchmark index will determine the Fund’s investment performance. Net asset value may be prone to high volatility on occasions where compositions of the benchmark index exhibit extreme volatility. The Fund's sub-funds may invest in US 144A bonds, which are privately offered and are more likely to have insufficient liquidity, incomplete disclosure of financial information or greater volatility due to opaque prices. "ICE 15+ Year AAA-AA US Corporate Constrained Index (ICE 15+ Year AAA-AA US Corporate Constrained Index)", ICE 15-year-old public utility corporate bonds (excluding foreign companies issued) ICE 15+ Year US Utility excluding Yankee Index)” and the ICE International 15+ Year US Emerging Markets External Sovereign Index (ICE International 15+ Year US Emerging Markets External Sovereign Index) SM/® (hereinafter referred to as “series Index)” is the service/business seal of ICE Data or its affiliated companies, and has been authorized together with the series of indices for Capital Investment Trust to target the Capital Investment Grade Bond ETF Umbrella Securities Investment Trust Fund (hereinafter referred to as “the Fund ") Use it. ICE Data and its suppliers do not make any relevant statements or guarantees, especially regarding the wisdom of securities investment in the product, the ability of trust or index to track general market performance. ICE Data is not responsible for nor involved in determining the timing, price or quantity of products to be issued, or decisions or formula settlement based on product pricing, sales, subscription or redemption. Except for specific custom index settlement services, all information provided by ICE Data is general information, and is not tailor-made information for Capital Investment Trust or any other person, entity or legal entity. ICE Data has no obligation and is not responsible for managing, marketing or trading products. ICE Data is not an investment advisor. ICE Data does not recommend the purchase, sale or holding of securities included in the index. Securities included in the index shall not be regarded as investment advice.

CAPITAL ICE 25+ YEAR US TREASURY EXCHANGE TRADED FUND; CAPITAL ICE 0-10 YEAR CHINA POLICY BANK EXCHANGE TRADED FUND
 
All sub-funds of the Fund are passively managed. They adopt the strategy of replicating and tracking performance of the benchmark index, which are the goals of the Fund's portfolio management. The movement of the benchmark index will determine the Fund’s investment performance. Net asset value may be prone to high volatility on occasions where compositions of the benchmark index exhibit extreme volatility. "ICE 25+ Year US Treasury Index (ICE 25+ Year US Treasury Index)" and "ICE 0-10 Year Laddered Maturity China Policy Bank Index (ICE 0-10 Year Laddered Maturity China Policy Bank Index)" "SM/® (hereinafter referred to as "series index)" is the service/business seal of ICE Data or its affiliated companies, and has been authorized together with the series index ("ICE Data and its suppliers"). ICE Data and its suppliers do not make any relevant statements or guarantees, especially regarding the wisdom of securities investment in the product, the ability of trust or index to track general market performance. ICE Data is not responsible for nor involved in determining the timing, price or quantity of products to be issued, or decisions or formula settlement based on product pricing, sales, subscription or redemption. ICE Data has no obligation and is not responsible for managing, marketing or trading products. ICE Data is not an investment advisor. ICE Data does not recommend the purchase, sale or holding of securities included in the index. Securities included in the index shall not be regarded as investment advice.

CAPITAL ICE 15+ YEAR SINGLE-A US CORPORATE EXCHANGE TRADED FUND; CAPITAL ICE 15+ YEAR AAA-A US HEALTHCARE EXCHANGE TRADED FUND;CAPITAL ICE 7+ YEAR CHINA POLICY BANK EXCHANGE TRADED FUND 
All sub-funds of the Fund are passively managed. They adopt the strategy of replicating and tracking performance of the benchmark index, which are the goals of the Fund's portfolio management. The movement of the benchmark index will determine the Fund’s investment performance. Net asset value may be prone to high volatility on occasions where compositions of the benchmark index exhibit extreme volatility. The Fund's sub-funds can invest in US 144A bonds. Bonds are of a private placement nature and are more likely to have insufficient liquidity, incomplete disclosure of financial information or greater volatility due to opaque prices. "ICE 15+ Year Single-A Large Cap Developed Markets US Corporate Index (ICE 15+ Year Single-A Large Cap Developed Markets US Corporate Index)", ICE 15-year or older AAA-A mature market US dollar corporate bonds Index (ICE 15+ Year AAA-A Large Cap Developed Markets US Healthcare Index) and ICE 7+ Year Large Cap China Policy Bank Constrained Index (ICE 7+ Year Large Cap China Policy Bank Constrained Index) ) SM/® (hereinafter referred to as the "series index)" is the service/business seal of ICE Data or its affiliates (hereinafter referred to as the "fund"). ICE Data and its suppliers do not make any relevant statements or guarantees, especially regarding the wisdom of securities investment in the product, the ability of trust or index to track general market performance.. ICE Data is not responsible for nor involved in determining the timing, price or quantity of products to be issued, or decisions or formula settlement based on product pricing, sales, subscription or redemption. Except for specific customary index settlement services, all information provided by ICE Data is general information and is not tailor-made information or any other person, entity or legal entity. ICE Data has no obligation and is not responsible for managing, marketing or trading products. ICE Data is not an investment advisor. ICE Data does not recommend the purchase, sale or holding of securities included in the index. Securities included in the index shall not be regarded as investment advice.

CAPITAL ICE BofA 0-1 YEAR US TREASURY EXCHANGE TRADED FUND; CAPITAL ICE 1-5 YEAR US CORPORATE EXCHANGE TRADED
FUND
 
All sub-funds of the Fund are passively managed. They adopt the strategy of replicating and tracking performance of the benchmark index, which are the goals of the Fund's portfolio management. The movement of the benchmark index will determine the Fund’s investment performance. Net asset value may be prone to high volatility on occasions where compositions of the benchmark index exhibit extreme volatility. [CAPITAL ICE 1-5 YEAR US CORPORATE EXCHANGE TRADED FUN] Up to 10% of the total assets of the fund can be invested in bonds that meet the requirements of Rule144A in the United States. The bonds are of a private placement nature and are more likely to have insufficient liquidity, incomplete disclosure of financial information or The risk of greater volatility due to opaque prices. "ICE BofAML 0-1 Year US Government Bond Index (ICE BofAML 0-1 Year US Treasury Index)" and "ICE 1-5 Year Mature Market Super Large USD Corporate Bond (Issue Period Within 6 Years) Index (ICE BofAML 0-1 Year US Treasury Index) 1-5 Year US Ultra Large Cap Developed Markets Corporate Maximum 6-Year Original Maturity Index) "SM/® (hereinafter referred to as the "series index)" is the service/business mark of ICE Data or its affiliates, and has been linked to the series index. ICE Data and its suppliers do not make any relevant statements or guarantees, especially regarding the wisdom of securities investment in the product, the ability of trust or index to track general market performance. The only relationship between ICE Data and Capital Investment Trust is limited to the authorization of specific trademarks, trade names, and indexes or index components. The index is determined, composed and settled by ICE Data. ICE Data is not responsible for nor involved in determining the timing, price or quantity of products to be issued, or decisions or formula settlement based on product pricing, sales, subscription or redemption. Except for specific custom index settlement services, all information provided by ICE Data is general information. ICE Data has no obligation and is not responsible for managing, marketing or trading products. ICE Data is not an investment advisor. ICE Data does not recommend the purchase, sale or holding of securities included in the index. Securities included in the index shall not be regarded as investment advice.

By entering you agree to fund disclaimer